Ther Adv Infect Dis. 2021 Apr 20;8:20499361211009385. doi: 10.1177/20499361211009385. eCollection 2021.
COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review.
Therapeutic advances in infectious disease
Sonia Poenaru, Sara J Abdallah, Vicente Corrales-Medina, Juthaporn Cowan
Affiliations
Affiliations
- Department of Medicine, The Ottawa Hospital, General Campus, 501 Smyth Road, Box 206, Ottawa, Ontario, K1H 8L6, Canada.
- Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
PMID: 33959278
PMCID: PMC8060761 DOI: 10.1177/20499361211009385
Abstract
Coronavirus disease 2019 (COVID-19) is a viral infection which can cause a variety of respiratory, gastrointestinal, and vascular symptoms. The acute illness phase generally lasts no more than 2-3 weeks. However, there is increasing evidence that a proportion of COVID-19 patients experience a prolonged convalescence and continue to have symptoms lasting several months after the initial infection. A variety of chronic symptoms have been reported including fatigue, dyspnea, myalgia, exercise intolerance, sleep disturbances, difficulty concentrating, anxiety, fever, headache, malaise, and vertigo. These symptoms are similar to those seen in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a chronic multi-system illness characterized by profound fatigue, sleep disturbances, neurocognitive changes, orthostatic intolerance, and post-exertional malaise. ME/CFS symptoms are exacerbated by exercise or stress and occur in the absence of any significant clinical or laboratory findings. The pathology of ME/CFS is not known: it is thought to be multifactorial, resulting from the dysregulation of multiple systems in response to a particular trigger. Although not exclusively considered a post-infectious entity, ME/CFS has been associated with several infectious agents including Epstein-Barr Virus, Q fever, influenza, and other coronaviruses. There are important similarities between post-acute COVID-19 symptoms and ME/CFS. However, there is currently insufficient evidence to establish COVID-19 as an infectious trigger for ME/CFS. Further research is required to determine the natural history of this condition, as well as to define risk factors, prevalence, and possible interventional strategies.
© The Author(s), 2021.
Keywords: COVID-19; chronic fatigue syndrome; human coronavirus; myalgic encephalomyelitis; post-infectious fatigue; review
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
References
- Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 20;103:109976 - PubMed
- Chest. 2012 Sep;142(3):583-592 - PubMed
- J Virol. 2004 Apr;78(7):3398-406 - PubMed
- J Infect. 2020 Dec;81(6):e4-e6 - PubMed
- J Intern Med. 2011 Oct;270(4):327-38 - PubMed
- Med J Aust. 2021 Apr;214(6):279-280 - PubMed
- Acta Neuropsychiatr. 2003 Oct;15(5):266-73 - PubMed
- J Transl Med. 2020 Jul 29;18(1):290 - PubMed
- J Transl Med. 2020 Feb 24;18(1):100 - PubMed
- Front Pediatr. 2018 Sep 04;6:242 - PubMed
- Vojnosanit Pregl. 2012 Oct;69(10):917-27 - PubMed
- Lancet. 1994 Sep 24;344(8926):864-8 - PubMed
- BMJ. 2020 Aug 11;370:m3026 - PubMed
- Arch Intern Med. 2007 Jun 25;167(12):1312-20 - PubMed
- Swiss Med Wkly. 2020 Jul 14;150:w20314 - PubMed
- Arch Intern Med. 2009 Dec 14;169(22):2142-7 - PubMed
- J Med Virol. 2021 Feb;93(2):1013-1022 - PubMed
- Thorax. 2020 Nov 10;: - PubMed
- J Transl Med. 2020 Jan 6;18(1):7 - PubMed
- Open Forum Infect Dis. 2020 Oct 21;7(11):ofaa507 - PubMed
- BMC Infect Dis. 2006 Jan 31;6:15 - PubMed
- J Virol. 2000 Oct;74(19):8913-21 - PubMed
- Viruses. 2019 Dec 20;12(1): - PubMed
- BMJ. 2020 Jul 31;370:m2923 - PubMed
- Am J Med. 2000 Nov;109(7):531-7 - PubMed
- Health Psychol Behav Med. 2015;3(1):82-93 - PubMed
- QJM. 2020 Sep 1;113(9):657-665 - PubMed
- Eur Respir J. 2020 Aug 6;56(2): - PubMed
- Bull IACFS ME. 2009;17(3):88-106 - PubMed
- Clin Infect Dis. 2005 Oct 15;41(8):1089-96 - PubMed
- Med Hypotheses. 2020 Nov;144:110055 - PubMed
- Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):318-26 - PubMed
- Brain Behav Immun. 2020 Jul;87:34-39 - PubMed
- Ann Intern Med. 1988 Mar;108(3):387-9 - PubMed
- PLoS One. 2020 Dec 11;15(12):e0243882 - PubMed
- Thorax. 2020 Dec 3;: - PubMed
- Ann Intern Med. 1994 Dec 15;121(12):953-9 - PubMed
- Cochrane Database Syst Rev. 2019 Oct 02;10:CD003200 - PubMed
- EClinicalMedicine. 2020 Aug;25:100463 - PubMed
- Lancet Psychiatry. 2020 Oct;7(10):875-882 - PubMed
- Psychiatry Investig. 2018 Apr;15(4):355-360 - PubMed
- BMJ. 2020 Jul 21;370:m2912 - PubMed
- Psychosom Med. 1999 May-Jun;61(3):304-10 - PubMed
- J Rehabil Med. 2020 May 25;52(5):jrm00063 - PubMed
- JAMA. 2020 Aug 11;324(6):603-605 - PubMed
- Psychol Med. 2003 Oct;33(7):1185-92 - PubMed
- Neuro Endocrinol Lett. 2009;30(6):677-93 - PubMed
- Brain Behav Immun. 2016 Mar;53:131-137 - PubMed
- BMC Neurol. 2019 Aug 24;19(1):207 - PubMed
- BBA Clin. 2014 Jun 1;1:12-23 - PubMed
- Ann Intern Med. 2021 Apr;174(4):576-578 - PubMed
- Lancet Psychiatry. 2020 Jul;7(7):611-627 - PubMed
- Ir J Psychol Med. 2020 Dec;37(4):295-300 - PubMed
- Respirology. 2010 Apr;15(3):543-50 - PubMed
- Clin Infect Dis. 2008 Dec 1;47(11):1418-25 - PubMed
- Neurosci Biobehav Rev. 2019 Dec;107:69-83 - PubMed
- JAMA. 2015 Mar 17;313(11):1101-2 - PubMed
- Clin Epidemiol. 2016 May 17;8:97-107 - PubMed
- Lancet. 2006 Jan 28;367(9507):346-55 - PubMed
- Clin Microbiol Infect. 2021 Jan;27(1):89-95 - PubMed
- Br J Psychiatry. 1998 Dec;173:475-81 - PubMed
- Brain Behav Immun. 2020 Jul;87:18-22 - PubMed
- Clin Infect Dis. 2020 Nov 30;: - PubMed
- J Transl Med. 2018 Oct 1;16(1):268 - PubMed
- BMJ. 2020 Jun 23;369:m2490 - PubMed
- Pharmacogenomics. 2006 Apr;7(3):407-19 - PubMed
- Biol Psychiatry. 1991 Oct 15;30(8):747-52 - PubMed
- In Vivo. 2010 Mar-Apr;24(2):185-8 - PubMed
- Clin Infect Dis. 1994 Jan;18 Suppl 1:S32-42 - PubMed
- Brain Behav Immun. 2012 May;26(4):552-8 - PubMed
- Iran J Public Health. 2020 Nov;49(11):2120-2127 - PubMed
- Fatigue. 2014;2(3):132-152 - PubMed
- Eur Respir J. 2020 Nov 26;56(5): - PubMed
- Sci Rep. 2017 Dec 8;7(1):17275 - PubMed
- J Transl Med. 2020 Jul 29;18(1):289 - PubMed
- Ann Clin Transl Neurol. 2020 Oct;7(10):2057-2071 - PubMed
- Vaccine. 2015 Nov 17;33(46):6173-7 - PubMed
- Ann Intern Med. 2020 Dec 8;: - PubMed
- Pain. 2020 Aug;161(8):1694-1697 - PubMed
- BMC Health Serv Res. 2020 Dec 20;20(1):1144 - PubMed
- Thorax. 2020 Dec 3;: - PubMed
- N Engl J Med. 2003 Feb 20;348(8):683-93 - PubMed
- Pediatrics. 2009 Jul;124(1):189-93 - PubMed
- Clin Infect Dis. 1996 Aug;23(2):408-9 - PubMed
- Brain Behav Immun. 2010 Oct;24(7):1209-17 - PubMed
- PLoS One. 2020 Apr 30;15(4):e0232475 - PubMed
- Thorax. 2020 Nov;75(11):1009-1016 - PubMed
- Viral Immunol. 2014 Sep;27(7):327-33 - PubMed
- Am J Respir Crit Care Med. 2006 Sep 1;174(5):538-44 - PubMed
- BMJ. 2006 Sep 16;333(7568):575 - PubMed
- BMC Neurol. 2011 Mar 24;11:37 - PubMed
- JAMA. 2020 Nov 3;324(17):1723-1724 - PubMed
- Neurophysiol Clin. 2017 Apr;47(2):131-138 - PubMed
- Acta Neuropathol. 1991;83(1):61-5 - PubMed
- Front Neurol. 2020 Aug 11;11:826 - PubMed
Publication Types